Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.49 |
| ▸ | MDM4 | O15151 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31355420 | 1.00 | CASP3 (0.49) | CASP3MDM4TP53CTSLCTSB | |
| SCHEMBL29052325 | 0.90 | CASP3 (0.45) | CASP3MDM4TP53CTSLCTSB | |
| SCHEMBL31453529 | 0.89 | CASP3 (0.45) | CASP3MDM4TP53CTSLCTSB | |
| SCHEMBL29858341 | 0.86 | CASP3 (0.45) | CASP3MDM4TP53PIN1 | |
| SCHEMBL32669193 | 0.86 | CASP3 (0.52) | CASP3MDM4TP53KMT2A | |
| SCHEMBL24580508 | 0.86 | CASP3 (0.41) | CASP3MDM4TP53CTSLCTSB | |
| SCHEMBL29697630 | 0.86 | CASP3 (0.41) | CASP3MDM4TP53CTSLCTSB | |
| SCHEMBL30812611 | 0.86 | CASP3 (0.42) | CASP3MDM4TP53CTSLCTSB | |
| SCHEMBL30582698 | 0.85 | CASP3 (0.54) | CASP3MDM4TP53CTSLCTSB | |
| SCHEMBL31251126 | 0.85 | CASP3 (0.51) | CASP3CTSLCTSBCTSSPIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025130972-A1 | SYNTHETIC METHOD FOR TIRZEPATIDE | 深圳翰宇药业股份有限公司 | 2025-06-26 | — | — | WO | claimed |
| CN-119978100-A | Tizepa Process for producing peptide | 四川吉晟生物医药有限公司 | 2025-05-13 | — | — | CN | claimed |
| WO-2025092769-A1 | PREPARATION METHOD FOR DUAL GIP AND GLP-1 RECEPTOR AGONIST | 博瑞生物医药（苏州）股份有限公司 | 2025-05-08 | — | — | WO | claimed |
| CN-119930756-A | Preparation method of dual receptor agonist of GIP and GLP-1 | 博瑞生物医药（苏州）股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119350471-B | Tenipout peptide synthesis method | 中肽生化有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119529056-A | Solid phase preparation method of telipopeptide | 福建基诺厚普生物科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119350471-A | Tenipout peptide synthesis method | 中肽生化有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119331048-A | Synthesis method of telipopeptide key intermediate | 杭州信海医药科技有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119219745-A | Preparation of tel method of poisein | 深圳翰宇药业股份有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-119101141-A | Tenipout Process for producing peptide | 苏州天马医药集团天吉生物制药有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-118005767-A | Method for preparing Tirzepatide by combining solid and liquid | 柏佳薇(深圳)生物科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117304299-A | Preparation method of Tirzepatide | 深圳市健元医药科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117106055-A | Synthesis method of telipopeptide | 杭州思诺达医药科技有限责任公司 | 2023-11-24 | — | — | CN | claimed |
| CN-116425827-A | Short peptide Fmoc-L-Ile-Aib-OH and preparation method thereof | 成都郑源生化科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-116120403-A | Method for preparing Tirzepatide through solid phase | 成都普康唯新生物科技有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-121914206-A | Preparation method of short peptide Fmoc-Ile-Aib-Leu (S) -Asp (tBu) -OH and intermediate thereof | 扬州奥锐特药业有限公司 | 2026-04-24 | — | — | CN | disclosed |
| CN-119529056-B | Solid phase preparation method of telipopeptide | 福建基诺厚普生物科技有限公司 | 2025-12-02 | — | — | CN | disclosed |
| CN-115806593-A | Fatty acid chain modified double-receptor agonist and application thereof | 成都普康生物科技有限公司 | 2023-03-17 | — | — | CN | disclosed |
| CN-115651075-A | Synthesis method of Tirzepatide | 杭州信海医药科技有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-115160429-A | Preparation method of Tirzepatide | 深圳市健元医药科技有限公司 | 2022-10-11 | — | — | CN | disclosed |